HIV vaccine
OHSU offers select multimedia assets for use by news outlets. (Commercial use is prohibited without prior written consent.)
When using these materials, please:
-
Credit photos and video with “OHSU/Photographer name.” Photographer name, caption and usage restrictions are embedded in the image metadata. Do not alter the content/nature of the photo. Color correction and cropping are allowed.
-
Audio and video clips should be credited to OHSU.
For more information, please contact OHSU Strategic Communications at news@ohsu.edu or 503-494-8231.
Louis Picker, M.D.
Louis J. Picker, M.D., associate director of the OHSU Vaccine and Gene Therapy Institute and professor of pathology, molecular microbiology and immunology in the OHSU School of Medicine. (OHSU)
OHSU Picker VGTI
Researchers process blood samples in Dr. Louis Picker’s lab. (OHSU/Boone Speed Photography)
OHSU Picker VGTI
Louis Picker, M.D., of the Vaccine and Gene Therapy Institute at Oregon Health & Science University, June 29, 2016. (OHSU/Boone Speed Photography)
Klaus Frueh, Ph.D.
Klaus Frueh, Ph.D., senior scientist at the OHSU Vaccine and Gene Therapy Institute and
professor for molecular microbiology and immunology in the OHSU School of Medicine. (OHSU)
Scott Hansen, Ph.D.
Scott Hansen, Ph.D., an assistant scientist at the OHSU Vaccine and Gene Therapy Institute and associate professor
in the OHSU School of Medicine. (OHSU)
OHSU Picker VGTI
Louis Picker, M.D., of the Vaccine and Gene Therapy Institute at Oregon Health & Science University (left) speaks with Scott Hansen, Ph.D., June 29, 2016.
(OHSU/Boone Speed Photography)
VGTI
(Left to right) Sjoerd Van Den Worm, Wilma Perez and Geoffrey Diemer, the team of scientists at the Vaccine and Gene Therapy Institute who are generating the CMV-based HIV vaccine for clinical testing. (OHSU)
- Latest Stories
- Popular
